1. Home
  2. FLXS vs CABA Comparison

FLXS vs CABA Comparison

Compare FLXS & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLXS
  • CABA
  • Stock Information
  • Founded
  • FLXS 2001
  • CABA 2017
  • Country
  • FLXS United States
  • CABA United States
  • Employees
  • FLXS N/A
  • CABA N/A
  • Industry
  • FLXS Home Furnishings
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FLXS Consumer Discretionary
  • CABA Health Care
  • Exchange
  • FLXS Nasdaq
  • CABA Nasdaq
  • Market Cap
  • FLXS 250.5M
  • CABA 260.7M
  • IPO Year
  • FLXS N/A
  • CABA 2019
  • Fundamental
  • Price
  • FLXS $34.59
  • CABA $2.49
  • Analyst Decision
  • FLXS
  • CABA Strong Buy
  • Analyst Count
  • FLXS 0
  • CABA 8
  • Target Price
  • FLXS N/A
  • CABA $13.50
  • AVG Volume (30 Days)
  • FLXS 49.8K
  • CABA 5.9M
  • Earning Date
  • FLXS 10-20-2025
  • CABA 11-07-2025
  • Dividend Yield
  • FLXS 2.31%
  • CABA N/A
  • EPS Growth
  • FLXS 64.53
  • CABA N/A
  • EPS
  • FLXS 4.11
  • CABA N/A
  • Revenue
  • FLXS $447,505,000.00
  • CABA N/A
  • Revenue This Year
  • FLXS $3.93
  • CABA N/A
  • Revenue Next Year
  • FLXS $4.20
  • CABA N/A
  • P/E Ratio
  • FLXS $8.44
  • CABA N/A
  • Revenue Growth
  • FLXS 6.00
  • CABA N/A
  • 52 Week Low
  • FLXS $29.38
  • CABA $0.99
  • 52 Week High
  • FLXS $65.87
  • CABA $5.46
  • Technical
  • Relative Strength Index (RSI)
  • FLXS 33.18
  • CABA 47.91
  • Support Level
  • FLXS $34.00
  • CABA $2.39
  • Resistance Level
  • FLXS $35.41
  • CABA $3.67
  • Average True Range (ATR)
  • FLXS 1.84
  • CABA 0.34
  • MACD
  • FLXS 0.01
  • CABA -0.04
  • Stochastic Oscillator
  • FLXS 5.27
  • CABA 8.78

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: